| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 444,105 | 423,358 | 408,678 | 408,324 | | Cost of Revenue | 108,595 | 102,573 | 97,705 | 98,566 | | | Gross Profit | 335,510 | 320,785 | 310,973 | 309,758 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 50,889 | 51,876 | 60,820 | 44,962 | | Non Recurring |
-
|
-
|
-
| 7,881 | | Others | 105,543 | 102,463 | 99,868 | 104,174 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 179,078 | 166,446 | 150,285 | 152,741 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (6,697) | (944) | 4,069 | 7,320 | | Earnings Before Interest And Taxes | 183,050 | 165,502 | 154,354 | 160,061 | | Interest Expense | 64,123 | 62,654 | 61,568 | 62,016 | | Income Before Tax | 118,927 | 102,848 | 92,786 | 98,045 | | Income Tax Expense | 51,348 | 51,428 | 37,107 | 15,255 | | Minority Interest |
-
|
-
|
-
| 97 | | | | Net Income From Continuing Ops | 67,582 | 51,427 | 55,689 | 82,891 | | | Non-recurring Events | | Discontinued Operations | (3) | 5,060 | 3,070 | 2,948 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 66,999 | 56,487 | 58,759 | 85,839 | | Preferred Stock And Other Adjustments | 356 | (198) | (158) |
-
| | | Net Income Applicable To Common Shares | $67,355 | $56,289 | $58,601 | $85,839 |
|
0.02% Nasdaq 0.00%
Income Statement
